BG T&A Co. (KOSDAQ:046310)
2,320.00
-10.00 (-0.43%)
At close: Sep 18, 2026
BG T&A Co. Market Cap
BG T&A Co. has a market cap or net worth of 37.31 billion as of September 18, 2026. Its market cap has decreased by -13.91% in one year.
Market Cap
37.31B
Enterprise Value
48.46B
Revenue
144.65B
Ranking
n/a
PE Ratio
13.15
Stock Price
2,320.00
ChartMarket Cap Chart
Since March 3, 2003, BG T&A Co.'s market cap has increased from 18.03B to 37.31B, an increase of 106.94%. That is a compound annual growth rate of 3.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 37.31B | -34.18% |
| Dec 30, 2025 | 56.69B | 60.59% |
| Dec 30, 2024 | 35.30B | -30.65% |
| Dec 28, 2023 | 50.90B | 1.31% |
| Dec 29, 2022 | 50.24B | -26.18% |
| Dec 30, 2021 | 68.06B | 36.80% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| YounglimwonSoftLab Co.Ltd | 37.00B |
| Nature & Environment | 36.85B |
| Korean Drug | 36.83B |
| Photon | 36.83B |
| Kolmar BioTech | 36.77B |
| Nable | 36.75B |
| Seoulin Bioscience | 36.40B |
| Biotoxtech | 36.08B |